Today's News | Note: News feeds may no longer be available for the articles on this page.

China's Sinovac enters race for flu vaccine 7:30 AM 6/15/2009
Reuters - USA
Chinese vaccine maker Sinovac Biotech Ltd plans to put its H1N1 vaccine through its first clinical trial by the end of July. WHO declared a pandemic last Thursday. ...

Glaxo To Pull Out Of Cancer-Drug Venture With Synta 5:35 AM 6/15/2009
Wall Street Journal - USA
Synta Pharmaceuticals Corp's cancer-drug venture with GlaxoSmithKline PLC will end within 3 months. ...

Pfizer Looking for Mideast Acquisitions, Forecasts 10% Growth 2:23 PM 6/14/2009
Bloomberg - USA
Pfizer plans to add $3 billion in annual revenue from sales in developing countries by 2012. ...

Obama outlines $313 billion in Medicare, Medicaid spending cuts 6:32 AM 6/14/2009
Los Angeles Times - CA,USA
President Obama outlined $313 billion in Medicare and Medicaid spending cuts over the next 10 years to help cover the cost of expanding insurance coverage to tens of millions currently uninsured. ...

Zyprexa suit highlights CVS links to Lilly 8:32 AM 6/13/2009
Boston Globe - United States
Pharmacy benefit managers (PBMs) are negotiating hidden deals while telling employers that they represent them at the negotiating table. ...

US FDA asks for caution on Merck asthma drug 3:20 PM 6/12/2009
Reuters - USA
Merck & Co's Singulair, AstraZeneca's Accolate, and Cornerstone Therapeutics' Zyflo should come with a caution about agitation, aggression, suicidal thinking, suicide, depression, insomnia, and irritability. ...

Dodd's wife serves on health care company boards 11:38 AM 6/12/2009
The Associated Press
The wife of Sen. Chris Dodd serves on the boards of Javelin Pharmaceuticals, Cardiome Pharma, and Brookdale Senior Living. Dodd is filling in for ailing Edward Kennedy who is chairman of the Health, Education, Labor and Pensions Committee which will start work on a healthcare bill. ...

US FDA cites safety issues with Savient gout drug 9:18 AM 6/12/2009
Reuters - USA
Savient Pharmaceuticals' proposed gout drug Krystexxa appears effective, but the FDA says serious heart complications and other safety issues are a concern. ...

US lawmakers tussle over generic biologic drugs 3:36 PM 6/11/2009
Reuters - USA
US lawmakers discuss biotechnology drug exclusivity in a hearing called to discuss a Federal Trade Commission report on the issue. ...

Regeneron will not submit ovarian cancer drug data 12:30 PM 6/11/2009
Reuters - USA
Regeneron Pharmaceuticals and Sanofi-Aventis will not submit data from the mid-stage study of their experimental drug aflibercept to treat ovarian cancer. It was difficult to assess the overall clinical benefit from the treatment. ...

Pfizer oral drug may shake up arthritis market 11:20 AM 6/11/2009
Reuters - USA
The experimental oral drug CP-690,550 from Pfizer could shake up the rheumatoid arthritis market. It may prove a cheaper and more convenient alternative to costly anti-TNF biotech treatments. ...

The Flu Pandemic Rally 10:20 AM 6/11/2009
Forbes - NY,USA
The World Health Organization declares the first global flu pandemic in four decades. Top vaccine producers were benefiting from a rally in their share prices. ...

Human Genome's Lupus Drug Shows Success in Trials 7:35 AM 6/11/2009
Wall Street Journal - USA
A midstage trial by Human Genome Sciences showed sustained ability to reduce flare-ups caused by lupus. ...

Transcept sees 3-month extension for sleep drug review 7:15 AM 6/11/2009
Reuters - USA
Transcept Pharmaceuticals expects a three month US FDA review extension for its experimental sleep aid Intermezzo. ...

FTC Opposes Biotech Industry Position On Generic Biologic Drugs 4:43 AM 6/11/2009
Wall Street Journal - USA
The US Federal Trade Commission said it supports giving the FDA the authority to approve generic biologic drugs to reduce costs and opposes a 12-14 year exclusivity period to market innovator medicines. More posturing without substance. ...

<- Day Earlier | Today's News